{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "esgPopulated": false, "market": "dr_market", "longName": "MyMD Pharmaceuticals, Inc.", "marketState": "REGULAR", "regularMarketPrice": 1.55, "messageBoardId": "finmb_694917951", "exchange": "FRA", "shortName": "MYMD PHARMAC.INC. DL-,01", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Berlin", "regularMarketChangePercent": -8.28403, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.69499993, "fiftyTwoWeekLowChangePercent": 0.8128654, "fiftyTwoWeekRange": "0.855 - 5.7", "fiftyTwoWeekHighChange": -4.1499996, "fiftyTwoWeekHighChangePercent": -0.72807014, "fiftyTwoWeekLow": 0.855, "fiftyTwoWeekHigh": 5.7, "earningsTimestamp": 1680292800, "earningsTimestampStart": 1684180800, "earningsTimestampEnd": 1684526400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.4, "firstTradeDateMilliseconds": 1618898400000, "priceHint": 4, "regularMarketChange": -0.1400001, "regularMarketTime": 1683872401, "regularMarketDayHigh": 1.55, "regularMarketDayRange": "1.55 - 1.55", "regularMarketDayLow": 1.55, "regularMarketVolume": 75, "regularMarketPreviousClose": 1.69, "bid": 1.6, "ask": 1.66, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.55, "averageDailyVolume3Month": 67, "averageDailyVolume10Day": 0, "sharesOutstanding": 39470000, "bookValue": 0.369, "fiftyDayAverage": 1.6254, "fiftyDayAverageChange": -0.075399995, "fiftyDayAverageChangePercent": -0.04638858, "twoHundredDayAverage": 2.238875, "twoHundredDayAverageChange": -0.68887496, "twoHundredDayAverageChangePercent": -0.307688, "marketCap": 61178500, "priceToBook": 4.200542, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "DQS.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "855 North Wolfe Street", "address2": "Suite 601", "city": "Baltimore", "state": "MD", "zip": "21205", "country": "United States", "phone": "(856) 848-8698", "website": "https://www.mymd.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher C. Chapman Jr., M.D.", "age": 69, "title": "Pres, Chief Medical Officer & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": {"raw": 261827, "fmt": "261.83k", "longFmt": "261,827"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Adam  Kaplin M.D., Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 353733, "fmt": "353.73k", "longFmt": "353,733"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul M. Rivard Esq.", "age": 51, "title": "Chief Legal Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 188239, "fmt": "188.24k", "longFmt": "188,239"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ian  Rhodes CPA", "age": 49, "title": "Interim Chief Financial Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}